Last Updated: May 09, 2024
molecularresidualdisease.com has 4 NS records, 9 A records, 0 AAAA records, 0 MX records, and 0 TXT records. Name servers for molecularresidualdisease.com are ns-246.awsdns-30.com, ns-1467.awsdns-55.org, ns-700.awsdns-23.net, ns-1860.awsdns-40.co.uk. A records for molecularresidualdisease.com are 52.92.129.195, 52.92.251.163, 52.92.238.195, 52.92.188.251, 52.218.153.34, 52.92.211.147, 52.92.211.11, 52.218.183.179, 52.92.202.123. We have observed molecularresidualdisease.com to have 1 subdomains. A subdomain count of 1 is considered a small digital footprint. The domain's primary website is hosted on a AmazonS3 web server at 52.92.161.75 in United States. The website's description is: "signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it."
Search DigitalStakeout Footprint to find another asset.
52.92.129.195
52.92.251.163
52.92.238.195
52.92.188.251
52.218.153.34
52.92.211.147
52.92.211.11
52.218.183.179
52.92.202.123
No DNS AAAA records
No DNS MX records
ns-246.awsdns-30.com
ns-1467.awsdns-55.org
ns-700.awsdns-23.net
ns-1860.awsdns-40.co.uk
No DNS TXT records
molecularresidualdisease.com has 1 subdomains in our inventory.
AmazonS3
52.92.161.75
United States
og:locale: en_us
og:type: article
og:title: signatera overview
og:description: signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it.
og:url: https://www.natera.com/oncology/signatera-advanced-cancer-detection/
og:site_name: natera
article:publisher: https://www.facebook.com/nateragenetics
article:modified_time: 2024-04-25t23:12:21+00:00
og:image: https://www.natera.com/wp-content/uploads/2022/08/icon-medicare.png
No certificate log entry found for molecularresidualdisease.com. Please check back at a later time.